Recursion Pharmaceuticals-a Earnings logo

RXRX

Recursion Pharmaceuticals-a Earnings

$6.95

Earnings Summary

Revenue
$26.08Mn
Net Profits
$-95.68Mn
Net Profit Margins
-366.82%
Highlights
Revenue:

Recursion Pharmaceuticals-a’s revenue jumped 158.19% since last year same period to $26.08Mn in the Q3 2024. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 80.91% jump in its revenue since last 3-months.

Net Profits:

Recursion Pharmaceuticals-a’s net profit fell -2.86% since last year same period to $-95.68Mn in the Q3 2024. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 1.91% jump in its net profits since last 3-months.

Net Profit Margins:

Recursion Pharmaceuticals-a’s net profit margin jumped 60.16% since last year same period to -366.82% in the Q3 2024. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 45.78% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Recursion Pharmaceuticals-a post its latest quarter earnings
EPS Estimate Current Quarter
-0.35
EPS Estimate Current Year
-0.35
Highlights
EPS Estimate Current Quarter:

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a 12.5% jump from last quarter’s estimates.

EPS Estimate Current Year:

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current year stand at -0.35.

Key Ratios

Key ratios of the Recursion Pharmaceuticals-a post its Q3 2024 earnings
Earning Per Share (EPS)
-0.34
Highlights
Earning Per Share (EPS):

Recursion Pharmaceuticals-a’s earning per share (EPS) jumped 20.93% since last year same period to -0.34 in the Q3 2024. This indicates that the Recursion Pharmaceuticals-a has generated 20.93% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-09
-0.42
-0.39
7.14%
2024-08-08
-0.4
-0.4
0%
2024-11-06
-0.35
-0.34
2.86%